Family history of end-stage renal disease does not predict dialytic survival

American Journal of Kidney Diseases

Volumn 38, Issue 3, 2001, Pages 547-552

  Freedman, Barry I ^a   Soucie, J Michael ^a,b   Kenderes, Barbara ^a,c   Krisher, Jenna ^a,d   Garrett, Leland E ^a,d   Caruana, Ralph J ^a,e   McClellan, William M ^a,e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Southeastern Kidney Council Inc End Stage Renal Disease Network 6   (United States)

^c Wake Nephrology   (United States)

^d EMORY UNIVERSITY   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Diabetic nephropathy; End stage renal disease (ESRD); Familial clustering; Hypertensive nephrosclerosis; Survival

Indexed keywords

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCULATION; CAUCASIAN; CONGESTIVE HEART FAILURE; DATA BASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEGRO; ONSET AGE; RELATIVE; SURVIVAL RATE;

EID: 0034874356     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.26851     Document Type: Article

References (16)

1. Familial aggregation of end-stage renal failure: Aetiological implications
2. Clinical and pathologic features of familial focal segmental glomerulosclerosis
3. Spectrum of disease in familial focal and segmental glomerulosclerosis
4. Family history of end-stage renal disease among incident dialysis patients
5. Regression models and life tables
6. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis
7. Racial differences in the incidence of hypertensive end-stage disease (ESRD) are not entirely explained by differences in the prevalence of hypertension
8. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
9. Race and endstage renal disease. Socioeconomic status and access to health care as mediating factors
10. Familial aggregation of renal disease in a populationbased case-control study
11. Genetic initiation of hypertensive and diabetic nephropathy
12. Genetic susceptibility to end-stage renal disease
13. Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis
14. Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity